Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations.

Cell proliferation - 1 Sept 2024

Wong Amanda Huee-Ping, Nga Min En, Chin Chin Yein, Tai Yee Kit, Wong Hung Chew, Soo Ross, An Omer, Yang Henry, Seet Ju Ee, Lim Yaw Chyn, Tam John Kit Chung, Tran Thai

Abstract excerpt

This study investigates CD151, a protein linked to cancer progression, in non-small cell lung cancer (NSCLC) patients without epidermal growth factor receptor (EGFR) mutations. These patients often have limited treatment options. The study used retrospective analysis to examine 157 adenocarcinoma biopsy specimens and 199 patient cases from The Cancer Genome Atlas, correlating CD151 expression with patient...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to ErbB Receptors

Share to Erlotinib Hydrochloride

Share to Lung Neoplasms

Share to Prognosis

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 38982031
DOI: 10.1111/cpr.13708
PMCID: PMC11503249

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations.PMID 38982031Read ↗

CD151—A Striking Marker for Cancer TherapySemantic proximity Read ↗

Key Role of CD151-integrin Complex in Lung Cancer Metastasis and Mechanisms Involved.Semantic proximity Read ↗

RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1Semantic proximity Read ↗

ALOX15, a new potential functional target of lung adenocarcinomaSemantic proximity Read ↗

The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and MetastasisSemantic proximity Read ↗

Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signalingSemantic proximity Read ↗

Evaluation of GDF15 Significance as a Biomarker in Laryngeal Squamous Cell CarcinomaSemantic proximity Read ↗

EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung CancerSemantic proximity Read ↗

RBM15 is a novel prognostic biomarker and correlates with immune cell infiltration in lung adenocarcinomaSemantic proximity Read ↗

The depletion of PinX1 involved in the tumorigenesis of non-small cell lung cancer promotes cell proliferation via p15/cyclin D1 pathwaySemantic proximity Read ↗

ISG15: A double edged sword in cancerSemantic proximity Read ↗

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.